People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Artio Medical, Inc. | — | Biotechnology | Series B | $62.6M | $70.7M | 2020 |
Nathaniel Nicholas Hagedorn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nathaniel Nicholas Hagedorn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sean Morris | 1 | 7 |
| James M. Schultz | 1 | 3 |
| Nathaniel Hagedorn | 1 | 3 |
| Frank Nicholas Franano | 1 | 2 |
| Jenny Nicholas Martin | 1 | 2 |
| Jeff M. Weinrich | 1 | 2 |
| Maria M. Sainz | 1 | 1 |
| Joseph M. McConnell | 1 | 1 |
| Abhinav M. Shukla | 1 | 1 |
| John M. Ayres | 1 | 1 |
| Maria Nicholas Sainz | 1 | 1 |
| Abhinav Nicholas Shukla | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.